| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ... Journal of thrombosis and haemostasis 4 (2), 295-306, 2006 | 8328 | 2006 |
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2560 | 2002 |
| A cell-based model of hemostasis M Hoffman, DM Monroe III Thrombosis and haemostasis 85 (06), 958-965, 2001 | 2122 | 2001 |
| Update of the guidelines for lupus anticoagulant detection V Pengo, A Tripodi, G Reber, JH Rand, TL Ortel, M Galli, PG De Groot Journal of Thrombosis and Haemostasis 7 (10), 1737-1740, 2009 | 1228 | 2009 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 1097* | 2015 |
| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines RA Asherson, R Cervera, PG De Groot, D Erkan, MC Boffa, JC Piette, ... Lupus 12 (7), 530-534, 2003 | 1044 | 2003 |
| Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2) RJ Dekker, S Van Soest, RD Fontijn, S Salamanca, PG De Groot, ... Blood, The Journal of the American Society of Hematology 100 (5), 1689-1698, 2002 | 834 | 2002 |
| Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain EG Huizinga, S Tsuji, RAP Romijn, ME Schiphorst, PG de Groot, JJ Sixma, ... Science 297 (5584), 1176-1179, 2002 | 699 | 2002 |
| Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity T Lisman, TN Bongers, J Adelmeijer, HLA Janssen, MPM de Maat, ... Hepatology 44 (1), 53-61, 2006 | 691 | 2006 |
| Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?[see comments] JD Oosting, RH Derksen, IW Bobbink, TM Hackeng, BN Bouma, ... | 684 | 1993 |
| Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study RT Urbanus, B Siegerink, M Roest, FR Rosendaal, PG de Groot, A Algra The Lancet Neurology 8 (11), 998-1005, 2009 | 517 | 2009 |
| The role of collagen in thrombosis and hemostasis RW Farndale, JJ Sixma, MJ Barnes, PG De Groot Journal of Thrombosis and Haemostasis 2 (4), 561-573, 2004 | 514 | 2004 |
| A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components KS Sakariassen, WPM Houdijk, JJ Sixma, PAMM Aarts, PG de Groot The Journal of laboratory and clinical medicine 102 (4), 522-535, 1983 | 503 | 1983 |
| Antiphospholipid syndrome K Schreiber, S Sciascia, PG De Groot, K Devreese, S Jacobsen, ... Nature reviews Disease primers 4 (1), 1-20, 2018 | 489 | 2018 |
| Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. JC De Graaf, JD Banga, S Moncada, RM Palmer, PG de Groot, JJ Sixma Circulation 85 (6), 2284-2290, 1992 | 489 | 1992 |
| IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis B De Laat, RHWM Derksen, RT Urbanus, PG De Groot Blood 105 (4), 1540-1545, 2005 | 475 | 2005 |
| Adhesion mechanism of human β2-glycoprotein I to phospholipids based on its crystal structure B Bouma, PG de Groot, JMH van den Elsen, RBG Ravelli, A Schouten, ... The EMBO journal 18 (19), 5166-5174, 1999 | 452 | 1999 |
| F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis SC Gouw, HM van den Berg, J Oldenburg, J Astermark, PG de Groot, ... Blood, The Journal of the American Society of Hematology 119 (12), 2922-2934, 2012 | 423 | 2012 |
| Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 ME Meltzer, T Lisman, PG de Groot, JCM Meijers, S le Cessie, ... Blood, The Journal of the American Society of Hematology 116 (1), 113-121, 2010 | 403 | 2010 |
| Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis T Lisman, FWG Leebeek, LO Mosnier, BN Bouma, JCM Meijers, ... Gastroenterology 121 (1), 131-139, 2001 | 354 | 2001 |
